Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve the unaudited financial ....
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divis Laboratories has informed the stock exchanges that its Board of Directors will meet on Friday, November 7, 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Q2 FY26 and H1 FY26). The trading window for dealing in the company's securities remains closed from October 1, 2025 until 48 hours after the results are declared, i.e., until November 9, 2025. This is a routine regulatory disclosure made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29). No financial figures have been disclosed in this filing.
No immediate impact on the stock — this is a standard pre-results intimation. The actual Q2 FY26 earnings on November 7 will be the next key catalyst, and the closed trading window means insiders cannot trade until November 9.